BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. (BBIO) has reported earnings 27 times since Dec 26, 2019. The stock moves an average of ±4.21% the day after reporting, closing higher 51.9% of the time. Its largest post-earnings gain was +12.12% (Aug 04, 2022) and its largest decline was -14.33% (Dec 26, 2019). The next earnings report is predicted for 2026-08-03 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
27
Avg Abs. Movement
±4.21%
Positive %
51.9%
Negative %
48.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $68.11 | $69.21 | $67.43 | 181,367 | +0.09% | open_in_new |
| Feb 24, 2026 | ☽ POST | $67.91 | $68.97 | $68.31 | 2,507,300 | -2.59% | open_in_new |
| Oct 29, 2025 | ☽ POST | $69.37 | $69.48 | $66.62 | 7,435,000 | -4.88% | open_in_new |
| Aug 05, 2025 | ☽ POST | $47.45 | $49.77 | $49.21 | 5,690,900 | -8.94% | open_in_new |
| Apr 29, 2025 | ☽ POST | $36.05 | $37.05 | $36.42 | 4,483,000 | +5.33% | open_in_new |
| Feb 20, 2025 | ☀ PRE | $39.40 | $39.47 | $36.80 | 7,245,700 | +1.42% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $26.16 | $26.62 | $24.62 | 2,425,200 | -5.74% | open_in_new |
| Aug 01, 2024 | ☀ PRE | $25.92 | $26.38 | $26.18 | 1,568,900 | +0.89% | open_in_new |
| May 02, 2024 | ☀ PRE | $27.60 | $27.87 | $27.74 | 1,201,800 | +2.63% | open_in_new |
| Feb 22, 2024 | ☀ PRE | $33.98 | $34.95 | $33.60 | 1,840,100 | -1.64% | open_in_new |
| Nov 02, 2023 | ☀ PRE | $26.77 | $27.60 | $26.92 | 1,546,000 | +1.01% | open_in_new |
| Aug 03, 2023 | ☀ PRE | $31.85 | $32.80 | $32.10 | 2,245,800 | +0.31% | open_in_new |
| May 04, 2023 | ☀ PRE | $14.22 | $14.49 | $13.50 | 2,112,400 | -6.25% | open_in_new |
| Feb 23, 2023 | ☀ PRE | $11.99 | $12.19 | $11.67 | 2,346,900 | -4.58% | open_in_new |
| Nov 03, 2022 | ☽ POST | $10.01 | $10.42 | $9.86 | 1,037,300 | -0.2% | open_in_new |
| Aug 04, 2022 | ☽ POST | $7.95 | $10.02 | $9.98 | 5,610,200 | +12.12% | open_in_new |
| May 10, 2022 | ☽ POST | $6.00 | $6.30 | $6.05 | 3,768,700 | -13.88% | open_in_new |
| Feb 24, 2022 | ☀ PRE | $7.27 | $8.06 | $8.00 | 5,169,500 | +8.99% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $49.92 | $51.98 | $51.46 | 639,800 | +2.9% | open_in_new |
| Aug 13, 2021 | ☽ POST | $50.70 | $52.11 | $50.12 | 317,800 | -1.28% | open_in_new |
| May 14, 2021 | ☽ POST | $50.88 | $53.94 | $53.66 | 708,600 | +0.88% | open_in_new |
| Feb 26, 2021 | ☀ PRE | $65.40 | $71.76 | $70.68 | 3,058,000 | +8.52% | open_in_new |
| Nov 05, 2020 | ☀ PRE | $40.17 | $42.19 | $40.99 | 681,900 | +2.42% | open_in_new |
| Aug 11, 2020 | ☀ PRE | $28.82 | $30.15 | $28.39 | 401,500 | -0.32% | open_in_new |
| May 13, 2020 | ☽ POST | $32.55 | $32.91 | $30.78 | 465,500 | -0.58% | open_in_new |
| Mar 02, 2020 | ☀ PRE | $32.22 | $33.65 | $32.21 | 837,100 | +1.04% | open_in_new |
| Dec 26, 2019 | ☽ POST | $45.68 | $46.68 | $43.00 | 295,800 | -14.33% | open_in_new |
Earnings Count
27
Total earnings in dataset
Avg Abs. Movement
±4.21%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260608 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260529 | open_in_new SEC.gov |
| 8-K | 20260527 | open_in_new SEC.gov |
| 4 | 20260526 | open_in_new SEC.gov |
| 144 | 20260521 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
Frequently asked about BBIO earnings
When does BridgeBio Pharma, Inc. report earnings next? expand_more
BridgeBio Pharma, Inc. (BBIO)'s next earnings date is approximate for 2026-08-03. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does BBIO stock move after earnings? expand_more
Over 27 reports, BBIO has moved an average of ±4.21% the session after earnings, closing higher 51.9% of the time.
What was BBIO's biggest post-earnings move? expand_more
BBIO's largest post-earnings gain on record was +12.12% on Aug 04, 2022, and its largest decline was -14.33% on Dec 26, 2019.
Where can I find BridgeBio Pharma, Inc.'s SEC filings? expand_more
All of BridgeBio Pharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right